NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ANAC - Anacor Pharmaceuticals Inc

Anacor Pharmaceuticals, Inc., incorporated on December 14, 2000, is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company has five product candidates in clinical development. Its three product candidates include two topically administered dermatologic compounds: A","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ANAChart

Anacor Pharmaceuticals Inc News


Arena Wins FDA Advisory Panel Backing for Obesity Pill
Proactive Investors USA & Canada - May 11, 2012
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 10, 2012. Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription ...

Earnings Results: AERL, AMCX, ANAC, APEI, ASYS, AVG, BBOX, BID, BRKS, CA, CDXS ...
Movie News Guide (blog) - May 10, 2012
Asia Entn & Resource (AERL) posted its quarterly earnings results on Thursday. The company reported $0.43 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.44 by $0.01.

Anacor Pharmaceuticals Reports First Quarter 2012 Financial Results
MarketWatch (press release) - May 10, 2012
PALO ALTO, Calif., May 10, 2012 (BUSINESS WIRE) -- Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the first quarter ended March 31, 2012.

Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates ...
BioMedReports (subscription) - May 4, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 4, 2012.

Anacor Pharmaceuticals Announces First Quarter 2012 Financial Results ...
MarketWatch (press release) - May 4, 2012
PALO ALTO, Calif., May 04, 2012 (BUSINESS WIRE) -- Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the quarter ended March 31, 2012, on Thursday, May 10, 2012 at approximately 4:00 pm ET / 1:00 pm PT.

Protalix Wins FDA Approval for Its First Drug; ISTA Reports Positive, Results ...
BioMedReports (subscription) - May 2, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 1, 2012.

Anacor Pharmaceuticals to Present at the Deutsche Bank Annual Health Care ...
MarketWatch (press release) - May 1, 2012
PALO ALTO, Calif., May 01, 2012 (BUSINESS WIRE) -- Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company's Chief Executive Officer, will provide a company overview at the Deutsche Bank Annual Health Care Conference on ...

Insider at Anacor Pharmaceuticals Inc (ANAC), Kirk Maples, sells $ 16388 of stock
MMD Newswire (press release) - Apr 25, 2012
PALO ALTO, CA (MMD Newswire) April 25, 2012 -- Kirk Maples sold 3000 shares of Anacor Pharmaceuticals Inc stock, or $16388 worth, as noted in an SEC Filing today.

Anacor Pharmaceuticals Inc Announces Sale Of 3.25 Million Shares Of Common Stock
Reuters Key Development - Feb 8, 2012

Anacor Pharmaceuticals Inc Announces Positive Preliminary Results From Two Safety Studies Of AN2728
Reuters Key Development - Feb 7, 2012

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>